@berlinergy · Long IBRX

$IBRX listen to the vision which is not a dream but Mission in the making: Immunotherapy 2.0 is the logical next phase. For the more than 15 mn U.S. patients already in complete remission, the limit is no longer tumor reduction, but durable immune control that prevents relapse.

Dr. Pat Soon-Shiong@DrPatrick

Best of wishes Michael and Congratulations . There are millions of patients with cancer worldwide who are in complete remission. The next frontier is to develop therapies strengthening the immune system to prevent recurrence in these over 15 million patients in the USA alone,

Read asLong IBRX

Since the call—

unrankedThe analyst's rank today

High · 0.97Confidence

Sun, Oct 4Tweeted

Mon, Oct 5 closeCounted from

not in the basket todayBasket

Rank per close

#208

Oct 5

#277

Oct 6

#198

Oct 7

—

Oct 8

#435

Oct 11

—

Oct 12

—

Oct 13

—

Oct 14

—

Oct 15